A consensus of poor ovarian response
qiao jie,ma caihong,liu jiayin,ma xiang,li shangwei,yang yezhou,zhang bo,la xiaolin,wang xiaohong,zhu yimin,chen zijiang,zhou congrong,xu yanwen,zhang songying,sun yun,zhang hanwang,ai jihui,sun yingpu,hu linli,li rong,sheng yan,lin ge,wu xueqing,liu ping
DOI: https://doi.org/10.7669/j.issn.0253-357X.2015.04.0211
2015-01-01
Abstract:One of the important content of assisted reproductive technology(ART) is ovarian stimulation,the application which can improve the clinical pregnancy rate, but increase multiple pregnancy, ovarian hyperstimulation syndrome(OHSS), and some other complication rates. The common used drugs for ovulation induced include clomiphene citrate(CC), aromatase inhibitors, gonadotropin(Gn), gonadotrophin-releasing hormone analog(Gn RHa) such as Gn RH-agonist(Gn RH-a) and Gn RH-antagonist(Gn RH-A). Drugs have different indications,contraindication and protocls. There are other ovulation stimulants including oral contraceptive(OC), metformin,dopmine receptor agonists, etc. The commonly used therapeutic evaluation index and calculation method are also introduced. Combining the study progress and clinical application of related fields domestic and abroad in recent years, some experts of Chinese Medical Association Reproductive Medicine Group reached a consensus on the application of ovarian stimulation in ART, in order to guide the standardization of its clinical use.